(Q38354341)

English

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement (English)

1 reference

Europe PubMed Central

2 September 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Viehmann S

1

1 reference

Europe PubMed Central

2 September 2017

Teigler-Schlegel A

2

1 reference

Europe PubMed Central

2 September 2017

Bruch J

3

1 reference

Europe PubMed Central

2 September 2017

Langebrake C

4

1 reference

Europe PubMed Central

2 September 2017

Reinhardt D

5

1 reference

Europe PubMed Central

2 September 2017

Harbott J

6

1 reference

Europe PubMed Central

2 September 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

17

1 reference

Europe PubMed Central

2 September 2017

6

1 reference

Europe PubMed Central

2 September 2017

1130-1136

1 reference

Europe PubMed Central

2 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402959

0 references

Structure and expression of the human MTG8/ETO gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

A quantitative reverse transcriptase polymerase chain reaction method for the detection of leukaemic cells with t(8;21) in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

21 January 2018

Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid disappearance of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia following bone marrow transplantation and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402959

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402959

1 reference

Europe PubMed Central

2 September 2017

Dimensions Publication ID

0 references

release_7jre6aqdqrc4nhhtlixv2zmfyu

1 reference

https://api.fatcat.wiki/v0/release/7jre6aqdqrc4nhhtlixv2zmfyu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38354341&oldid=1840271299"